Meda Pharmaceuticals USA

Home About Meda Pharmaceuticals Products Join Media Center Healthcare Professionals Contact Us

Media Center  |  Media Archive      


FDA Approves SOMAŽ (carisoprodol) 250 mg Product in the US
- [September, 2007]


Meda acquires exclusive rights to potential specialty blockbuster product in the US
- [September, 2007]


Strategic Acquisition of MedPointe Inc completed
- [August, 2007]


Meda enters the US market through the strategic acquisition of MedPointe Inc
- [July, 2007]


MedPointe Pharmaceuticals Announces the Appointment of John J.Howarth to Vice President of Public Affairs and Investor Relations
- [May, 2007]


MedPointe Settles Litigation with Hi-Tech and Successfully Enforces Patent Covering Its Tussi-12® D Products
- [May, 2007]







Further inquiries should be directed to info@medapharma.us